Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

7.530 -0.050 (-0.66%)
Streaming Delayed Price Updated: 9:30 AM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
64 65 Next >
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
 
Via Benzinga
Europe Approves Novavax's COVID-19 Vaccine Booster For Adults
 
Via Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
What Is Going on With Vaxart (VXRT) Stock Today?
Vaxart released encouraging results for its oral Covid-19 vaccine, though sentiment for VXRT stock presently remains mixed. 
Via InvestorPlace
Novavax Scores Another Nod For Its COVID-19 Shot In Adolescents
 
Via Benzinga
FDA Approves Novavax's COVID-19 Vaccine For Use In Adolescents
 
Via Benzinga
Novavax Seeks FDA Emergency Use Nod For Its COVID-19 Vaccine Booster
 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 297 companies achieved new lows for the year. 
Via Benzinga
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
Health Canada has approved Moderna Inc's (NASDAQ: 
Via Benzinga
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
Wall Street Journal 
Via Benzinga
HP, Ambarella, Bed Bath & Beyond And Other Big Losers From Wednesday
U.S. stocks closed lower with the Dow Jones dropping around 280 points on Wednesday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
Why Is Novavax (NVAX) Stock Down Today?
Pfizer and Moderna received FDA approval for their omicron-specific booster. NVAX stock is hitting new 52-week lows in response. 
Via InvestorPlace
Why Novavax Shares Are Getting Hammered After Moderna, Pfizer And BioNTech News
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc (NASDAQ: MRNA) receiving FDA authorization for emergency use... 
Via Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Novavax Obtains U.K. Regulatory Clearance For Nuvaxovid In Adolescents Aged 12-17 Years
The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) has granted expanded conditional marketing authorization (CMA) for Novavax’s (NASDAQ: NVAX) lead asset... 
Via Benzinga
Pfizer And Moderna Are In A Race With Omicron; Will The Vaccine Stocks Be Too Late?
The companies hope to launch updated boosters this fall. This is what experts think of their prospects. 
Via Investor's Business Daily
Face Of US COVID-19 Response, Dr Anthony Fauci To Retire In December
  
Via Benzinga
Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challenge, And It's Worth Billions
How they handle an upcoming shift in payments will be telling for their tailwind. 
Via Investor's Business Daily
Novavax's Covid-19 Vaccine Cleared For Use In New Zealanders Aged 12-17
 
Via Benzinga
If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than... 
Via Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
Biden Administration To Stop Purchasing COVID-19 Solutions By End Of 2022
 
Via Benzinga
Sanofi, Children's Place And Some Other Big Stocks Moving Lower On Wednesday
  Embark Technology, Inc. (NASDAQ: EMBK) fell 25.1% to $12.40. Embark Technology reported the completion of reverse stock split. 
Via Benzinga
Here's How Much You Would Have Made Owning Novavax Stock In The Last 5 Years
  Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 3.21% on an annualized basis producing an average annual return of 14.91%. Currently, Novavax has a market capitalization of... 
Via Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus... 
Via Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.